SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway

Rie Matsushima‐Nishiwaki(National Center for Geriatrics and Gerontology), Osamu Kozawa(Gifu University)

PLoS ONE

January 10, 2022

10.1371/journal.pone.0262485

Cited by 16

Related Papers

Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells

|Journal of Neuroinflammation|2010|179

Tumor Necrosis Factor-α Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells

|PLoS ONE|2013|88

(−)‐Epigallocatechin gallate suppresses endothelin‐1‐induced interleukin‐6 synthesis in osteoblasts: Inhibition of p44/p42 MAP kinase activation

|FEBS Letters|2007|41

Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax

|Oncology Reports|2014|39

Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells

|PLoS ONE|2016|35